IceCure Medical Ltd. (ICCM) Institutional Ownership

Ownership Summary

A total of 18 institutions have reported a stake in IceCure Medical Ltd. (NASDAQ:ICCM) as of December 2025, according to recent 13F filings with the SEC.

• IceCure Medical saw its institutional ownership percentage rose to 0.7% in December 2025 from 0.4% in September 2025.
• Quarterly data indicates a 89.52% shift in institutional share volume, and the annual owner count reflects an increase of 28.57%.
• A review of institutional activity for IceCure Medical shows 6 of 18 filers increasing their positions, while 2 reduced their stake, and 10 remained unchanged.
• Collectively, institutional investors increased their stake in IceCure Medical to 460.28K shares as of December 2025, a change that is up by 217.41K shares quarter on quarter and up 306.64K shares year over year.
• JANE STREET GROUP, LLC's holding of 109.64K shares as of December 31, 2025 makes it the primary institutional investor in IceCure Medical, owning 0.17% of the stock.
• Among the most significant buyers of IceCure Medical during December 2025 were JANE STREET GROUP, LLC (109.64K), Concurrent Investment Advisors, LLC (78.28K), UBS Group AG (70.52K), Wellington Shields Capital Management, LLC (15.00K), MORGAN STANLEY (2.70K).
• Leading sellers of IceCure Medical stock in December 2025 included HRT FINANCIAL LP (31.35K), TWO SIGMA SECURITIES, LLC (27.89K).
• The top 10 institutional holders of IceCure Medical for the quarter ending December 2025 included JANE STREET GROUP, LLC (109.64K), UBS Group AG (92.17K), Concurrent Investment Advisors, LLC (78.28K), GEODE CAPITAL MANAGEMENT, LLC (40.45K), LPL Financial LLC (23.38K), TWO SIGMA SECURITIES, LLC (22.28K), Gunderson Capital Management Inc. (20.00K), HRT FINANCIAL LP (15.35K), Wellington Shields Capital Management, LLC (15.00K), FOUNDATIONS INVESTMENT ADVISORS, LLC (15.00K).